Bristol-Myers Squibb to Hold Investor Event to Discuss AACR Highlights

NEW YORK NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will hold an investor event on Monday, April 16, 2018 at 6:00 p.m. EDT (5:00 p.m. CDT) to discuss data presented at the Annual Meeting of the American Association for Cancer Research (AACR) in Chicago. Company executives will provide an overview of data presented from the company’s oncology portfolio, and address questions from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the event at investor.bms.com. Materials related to the event will be available at the same website prior to the event. A replay of the event will be available and can be accessed at investor.bms.com.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180402005683/en/

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Lisa McCormick Lavery, 609-252-7602
[email protected]
or
Investors:
Tim Power, 609-252-7509
[email protected]
or
Bill Szablewski, 609-252-5894
[email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
• Bitget Wallet Identifies Stablecoins and Tokenized Assets as Crypto's Strongest Onchain Fundamentals
• New Crypto: Pepeto Presale Announces $10.85M As the Ethereum Price Prediction Calls $7,500